Rifaximin Prophylaxis Fails for Bacterial Peritonitis in Cirrhotic Patients

Source link :

Rifaximin prophylaxis was no better than placebo at preventing deaths and other negative outcomes from spontaneous bacterial peritonitis (SBP) in patients with severe cirrhosis, according to interim results of the phase III ProPILA-Rifax trial. In a modified intention-to-treat analysis, transplant-free survival after 12 months among French patients who took 550 mg of rifaximin twice daily […]

Author : News Health

Publish date : 2024-06-11 19:42:47

Copyright for syndicated content belongs to the linked Source.